About TYSABRI
TYSABRI is a company based in Durham (United States) founded in 2002, and was acquired by Biogen in February 2013. Infusion medication for infection prevention is developed and provided. Its website tysabri.com draws about 22 thousand monthly visits.
Company details
TYSABRI was founded in 2002 and is located in Durham, United States. Operations are conducted in the pharmaceutical sector, where infusion medications targeted at infection prevention are developed and distributed. The companys domain, tysabri.com, supports access to product information and related services. Focus is maintained on medical treatments administered via infusion to address preventive healthcare needs in the region.
- Headquarters Durham, United States
- Stage Acquired
- Website category Health · Pharmacy
- Phone•••• ••••
- Website tysabri.com
- Social Facebook
- Acquired by Biogen (Feb 2013)
Investors in TYSABRI
TYSABRI has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Biogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Therapies for neurodegenerative and immunology disorders are developed. | 1978 | biogen.com | Cambridge, United States |
Investor details for TYSABRI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of TYSABRI
2 dated milestones of TYSABRI across 11 years, from founding to its latest funding, stage changes and deals.
- Founded TYSABRI is founded.
- Exit Acquired by Biogen.
Web traffic of TYSABRI
The website of TYSABRI (tysabri.com) receives about 21.6K visits a month and ranks #479,440 among all websites worldwide, #886 in Pharmacy.
- Monthly visits21.6K
▼ 73.6% vs previous month
- Unique visitors60.8K
per month
- Global rank#479,440
among all websites
- Category rank#886
Health · Pharmacy
- Bounce rate77%
- Pages per visit1.6
- Average visit48 sec
- DevicesDesktop 3% · Mobile 97%
Websites whose visitors overlap most with TYSABRI. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
avonex.com | avonex.com | 100% | #3,420,020 | – | |
gilenya.com | gilenya.com | 100% | – | ||
tysabrihcp.com | tysabrihcp.com | 86% | #976,475 | – | |
| rituxan.com | 83% | 10.8K | #1,818,126 | View details | |
rebif.com | rebif.com | 80% | #6,799,124 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for TYSABRI
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about TYSABRI
TYSABRI was founded in 2002.
TYSABRI is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
TYSABRI was founded in 2002 and is located in Durham, United States. Operations are conducted in the pharmaceutical sector, where infusion medications targeted at infection prevention are developed and distributed. The companys domain, tysabri.com, supports access to product information and related services. Focus is maintained on medical treatments administered via infusion to address preventive healthcare needs in the region.
TYSABRI has 1 investor. Key investors include Biogen.
Yes. TYSABRI was acquired by Biogen in February 2013.